INSP Inspire Medical Systems

EY Names Tim Herbert, President & CEO of Inspire Medical Systems, Inc., Entrepreneur Of The Year® 2019 Award Winner in the Heartland

EY Names Tim Herbert, President & CEO of Inspire Medical Systems, Inc., Entrepreneur Of The Year® 2019 Award Winner in the Heartland

MINNEAPOLIS, July 01, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (“OSA”), announced today that EY has named Tim Herbert, President and Chief Executive Office of Inspire Medical Systems, Entrepreneur of the Year® 2019 in the Heartland. The award recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities. Mr. Herbert was selected by an independent panel of judges, and the award was presented on June 27, 2019, in Minneapolis.

“It is a great honor to be selected for this award. Bringing Inspire therapy to OSA patients has been my focus for over 20 years. The continued accelerated growth of Inspire is exciting to be a part of, but we will never lose sight of what is most important, which is that every patient counts” said Mr. Herbert. “I would like to thank my team at Inspire, my many mentors through the years, Inspire’s board members, and, most importantly, my wife and children. Without all of their support, Inspire wouldn’t be where it is today.”

Since 1986, EY has honored entrepreneurs whose ingenuity, spirit of innovation and discipline have driven their companies’ success, transformed their industries and made a positive impact on their communities.

As a Heartland award winner, Mr. Herbert is now eligible for consideration for the 2019 National Awards. Award winners in several national categories, as well as the Entrepreneur Of The Year National Overall Award winner, will be announced in Palm Springs, California, on November 16, 2019. The awards are the culminating event of the Strategic Growth Forum®.  For more information about EY’s Entrepreneur Of The Year®, please visit .

About Inspire Medical Systems

Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit .

Investor and Media Contact:

Bob Yedid

LifeSci Advisors



646-597-6989

EN
01/07/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Inspire Medical Systems

 PRESS RELEASE

Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Marke...

Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum MINNEAPOLIS, March 03, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the KeyBanc Capital Markets Healthcare Forum on Tuesday, March 17, 2026. Inspire is scheduled to present at 1:30 p.m. Eastern Time. The presentation will be accessible via a live w...

 PRESS RELEASE

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2...

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results Launch of Inspire V system complete with strong revenue and profitability performance in the fourth quarter and FDA approval for 3.0T MRI compatibility Fourth quarter revenue growth of 12% and full year revenue growth of 14%Fourth quarter net income per diluted share of $4.66; adjusted net income per diluted share of $1.65Full year net income per diluted share of $4.89; adjusted net income per diluted share of $2.42Operating cash flow of $52.5 million in the fourth quarter with full year operating ...

 PRESS RELEASE

Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue ...

Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance Inspire Announces Appointment of Matt Osberg as Executive Vice President and Chief Financial Officer Joining the Company in the First Quarter of 2026 MINNEAPOLIS, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”, or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep a...

 PRESS RELEASE

Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2...

Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and full year 2025 after the close of trading on Wednesday, February 11. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Ins...

 PRESS RELEASE

Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morga...

Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference MINNEAPOLIS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026. Inspire is scheduled to present at 12:45 p.m. Eastern Time. The presentation will be accessible vi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch